Skip to main content

Site notifications

AMBELVIST Bayer Australia Ltd

Product name
AMBELVIST
Accepted date
Sep-2025
Active ingredients
gadoquatrane
Proposed indication
Ambelvist (gadoquatrane) is for diagnostic use only. It is proposed as a contrast agent to be used during MRI (magnetic resonance imaging) scans. It improves the clarity of MRI images, allowing for better detection of known or suspected pathology in the central nervous system (CNS) and body, in adult and paediatric patients of all ages.
Application type
A (new medicine)
Publication date
Sep-2025